Search Results 391-400 of 17022 for pharmacogenetics

1. Patient Resources - Mayo Clinic Research

   View patient resources recommended by the Immuno-Epigenetics Lab led by William A. Faubion Jr., M.D., at Mayo Clinic's campus in Minnesota.

2. Medical Research & Education - Mayo Clinic News Network

   The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...

3. Education and training - Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

   The Biliary Epigenetics and Regenerative Medicine Laboratory of Robert C. Huebert, M.D., at Mayo Clinic provides training, education and career ...

4. A Study to Evaluate a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis - Mayo Clinic

   The purpose of this study is to characterize the risk of scoliosis progression based on local three-dimensional vertebral and pelvic measurements present on ...

5. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

   This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...

6. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

   The purpose of this study is to compare the effectiveness of temozolomide to selumetinib for the treatment of patients who have melanoma of the eye that has ...

7. Individualized Medicine for Cardiomyopathies - Zebrafish Genetics Lab: Xiaolei Xu - Mayo Clinic Research

   Mayo Clinic's Zebrafish Genetics Lab led by Xiaolei Xu, Ph.D., is discovering genes that help develop individualized medicine for idiopathic dilated ...

8. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

9. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

   Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...

10. Mayo Clinic Medical Edge Genetic Testing for Breast Cancer Intro

    Intro: It could be your mom, sister, aunt or best friend. One out of eight women will get breast cancer in her lifetime. A small subset of the women who get ...